Table 2.
The results of the contingency table testing.
| Parameter | COVID-19-Negative | COVID-19-Positive | Chi2 Test (p) |
|---|---|---|---|
| Male | 14 (42.42%) | 19 (67.86%) | 0.049 |
| Female | 19 (57.58%) | 9 (32.14%) | |
| Urban | 19 (57.58%) | 16 (57.14%) | 0.973 |
| Rural | 14 (42.42%) | 12 (42.86%) | |
| Parameter | COVID-19-negative | COVID-19-positive | Fisher’s exact test (p) |
| S. Aureus positive | 2 (6.06%) | 3 (10.71%) | 0.653 |
| S. Aureus negative | 31 (93.94%) | 25 (89.29%) | |
| Str. Pyogenes positive | 3 (9.09%) | 0 (0.00%) | 0.243 |
| Str. Pyogenes negative | 30 (90.91%) | 28 (100.00%) | |
| Str. Beta-hemolytic group G positive | 4 (12.12%) | 2 (7.14%) | 0.678 |
| Str. Beta-hemolytic group G negative | 29 (87.88%) | 26 (92.86%) | |
| Str. Beta-hemolytic group C positive | 5 (15.15%) | 3 (10.71%) | 0.715 |
| Str. Beta-hemolytic group C negative | 28 (84.85%) | 25 (89.29%) | |
| Hemophilus influenzae positive | 0 (0.00%) | 1 (3.57%) | 0.459 |
| Hemophilus influenzae negative | 33 (100.00%) | 27 (96.43%) | |
| History of A viral hepatitis positive | 0 (0.00%) | 4 (14.29%) | 0.039 |
| History of A viral hepatitis negative | 33 (100.00%) | 24 (85.71%) | |
| Active oral candidiasis positive | 0 (0.00%) | 6 (21.43%) | 0.007 |
| Active oral candidiasis negative | 33 (100.00%) | 22 (78.57%) |